BROOKLYN,NY –A three-count indictment was unsealed this afternoon in federal court in Brooklyn,New York,charging Xiaodong Wu,the founder,Chief Executive Officer and Chairman of the Board of Directors of China Medical Technologies,Inc.(China Medical),and Tak Yung Samson Tsang,also known as “Sam Tsang,”the Chief Financial Officer and a member of the Board of Directors of China Medical,with securities fraud,securities fraudconspiracy and wire fraud conspiracy.[1]Wu and Tsang are alleged to have defrauded China Medical’s noteholders and investors of more than $400million through misrepresentations about the use of proceeds raised through two note offerings and by then stealing the invested funds by transferring them to entities controlled by,or affiliated with,Wu and Tsang.The defendants are fugitives.

The charges were announced by Bridget M.Rohde,Acting United States Attorney for the Eastern District of New York,and William F.Sweeney,Jr.,Assistant Director-in-Charge,Federal Bureau of Investigation,New York Field Office (FBI).

“As alleged,Xiaodong Wu and Samson Tsang deceived unsuspecting investors who thought they were investing in a NASDAQ-listed medical device company but whose investments were stolen and fraudulently transferred to entities in China controlled by Wu and Tsang.The defendants’scheme defrauded the investing public of more than $400million,”stated Acting United States Attorney Rohde.“Today’s indictment further demonstrates our commitment to protecting investors and to holding accountable those who seek to abuse the financial markets to enrich themselves.”

“As alleged,Wu and Tsang led their victims down a narrow path of deceit.They betrayed the trust of those who took them at their word,stole their money,and made off with more than $400million.Whether you omit key facts or intentionally misrepresent the truth,defrauding investors is a crime you won’t get away with it,”stated FBI Assistant Director-in-Charge Sweeney.

As detailed in the indictment,between January 2005and November 2012,Wu and Tsang,together with their co-conspirators,orchestrated a scheme to defraud China Medical’s noteholders and investors through material misrepresentations and omissions relating to,among other things,the use of approximately $426million in investments and the subsequent transfer of these investments to entities controlled by,or affiliated with Wu and Tsang.China Medical issued three series of notes:(i)on or about November 21,2006,$150million of 3.5percent convertible senior subordinated notes due 2011(2011Notes);(ii)on or about August 15,2008,$276million of 4percent convertible senior notes due 2013(2013Notes);and (iii)on or about December 6,2010,$150million of 6.25percent convertible senior notes due 2016(2016Notes).

Wu and Tsang represented in the offering memoranda for the 2013Notes and 2016Notes that they would use the proceeds for general corporate purposes,for the acquisitions of businesses,products and technologies and to repurchase outstanding convertible notes.Contrary to these representations,most of the money raised through the 2013Notes and the 2016Notes was eventually transferred by Wu and Tsang to entities controlled by Wu,Tsang and their co-conspirators.For example,between November 3,2006and December 4,2008,approximately $303.75million of the approximately $576million that China Medical raised in its three note offerings was transferred to an entity that was owned by an associate of Wu and Tsang,and approximately $202million was subsequently transferred to bank accounts controlled by Wu.Additionally,the intellectual property that was the subject of the note offerings was approximately 20years old and off-patent,and any value it had was minimal.

To execute their fraudulent scheme,Wu and Tsang caused China Medical’s independent director and outside auditor to resign,stopped making public disclosures of material events affecting the value of its securities and stopped making interest payments on the notes.On August 31,2012,China Medical filed for Chapter 15bankruptcy protection in the Southern District of New York.

To date,$246.5million of the 2013Notes and $150million of the 2016Notes remain outstanding.

***

The criminal case has been assigned to United States District Judge Kiyo A.Matsumoto.If convicted,each of the defendants faces a maximum sentence of 20years’imprisonment.

***

The government’s case is being prosecuted by the Office’s Business and Securities Fraud Section.Assistant United States Attorneys Lauren H.Elbert and Winston M.Paes are in charge of the prosecution,with assistance provided by Assistant United States Attorney Tanya Hill of the Office’s Civil Division.

The Defendants:

XIAODONG WU

Age:59

Residence:PEOPLE’S REPUBLIC OF CHINA

TAK YUNG SAMSON TSANG,also known as “Sam Tsang”

Age:46

Residence:PEOPLE’S REPUBLIC OF CHINA

E.D.N.Y.Docket no.17-cr-144(Kam)

[1]The charges announced today are allegations,and the defendants are presumed innocent unless and until proven guilty.

Attachment(s):Download wu-tsang_indictment_0.pdfTopic(s):Financial FraudSecurities,Commodities,&Investment FraudStopFraudComponent(s):USAO -New York,EasternUpdated March 20,2017

(来源：继民财经汇微信公众号)

生成长微博 在线投稿 设本站为首页 收藏本站 猎头服务

我们尊重原创者版权，除非我们确实无法确认作者以外，我们都会注明作者和来源。在此向原创者表示感谢。本网转载文章完全是为了内部学习、研究之非商业目的，若是涉及版权等问题，烦请联系 service@execunet.cn 或致电 010-85885475 删除，谢谢！

发表评论：

主题：
内容：
	匿名发表验证码：登录名：密码：个人企业

发帖须知：

一、请遵守中华人民共和国有关法律法规、《全国人大常委会关于维护互联网安全的决定》及《互联网新闻信息服务管理规定》。
二、请注意语言文明，尊重网络道德，并承担一切因您的行为而直接或间接引起的法律责任。
三、管理员有权保留或删除其管辖留言中的任意内容。
四、您在本站发表的言论，本站有权在网站内转载或引用。
五、发表本评论即表明您已经阅读并接受上述条款。

企业找猎头

职业经理人找猎头

□医药医疗行业相关资讯

□医药医疗行业相关职位

京ICP备05025905号-1

京公网安备 110105001605号